We are live on
!
Find out more
Viking Global Investors Portfolio holdings
AUM
$35.7B
1-Year Est. Return
21.3%
This Fund
S&P 500
This Quarter
Est. Return
-4.78%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$36.5B
AUM Growth
+$3.48B
(+11%)
Cap. Flow
+$5.21B
Cap. Flow
% of AUM
14.28%
Top 10 Holdings %
Top 10 Hldgs %
38.65%
Holding
113
New
25
Increased
26
Reduced
33
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ginkgo Bioworks
DNA
|
+$4.13B |
| 2 |
Humana
HUM
|
+$1.03B |
| 3 |
Parker-Hannifin
PH
|
+$724M |
| 4 |
McDonald's
MCD
|
+$714M |
| 5 |
Brookfield
BN
|
+$696M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$936M |
| 2 |
Aon
AON
|
+$693M |
| 3 |
Palo Alto Networks
PANW
|
+$576M |
| 4 |
ServiceNow
NOW
|
+$559M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 38.33% |
| 2 | Technology | 18.92% |
| 3 | Industrials | 11.99% |
| 4 | Consumer Discretionary | 11.25% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
VTEX
VTEX
$670M
| $62.6M | 0.17% |
+3,040,896
| New | +$75.9M |
|
|
ATVI
77
DELISTED
Activision Blizzard
ATVI
| $61.6M | 0.17% |
+796,247
| New | +$66.5M |
|
78
MetLife
MET
$61.5B
| $59.2M | 0.16% |
+959,147
| New | +$57.7M |
|
79
Atea Pharmaceuticals
AVIR
$404M
| $58M | 0.16% |
+1,655,087
| New | +$45.9M |
|
|
ICVX
80
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $54.8M | 0.15% |
+1,852,789
| New | +$62.8M |
|
81
PMV Pharmaceuticals
PMVP
$69.3M
| $53.4M | 0.15% |
1,790,284
| – | – |
|
82
Edgewise Therapeutics
EWTX
$4.81B
| $45.3M | 0.12% |
2,727,249
| – | – |
|
|
TRML
83
DELISTED
Tourmaline Bio
TRML
| $44.6M | 0.12% |
328,962
| – | – |
|
|
KNTE
84
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $41.9M | 0.11% |
1,820,462
| – | – |
|
85
Pharvaris
PHVS
$2.41B
| $41.3M | 0.11% |
2,391,517
| – | – |
|
86
Celldex Therapeutics
CLDX
$3.48B
| $41.2M | 0.11% |
+762,296
| New | +$35.8M |
|
|
NUVL
87
DELISTED
Nuvalent
NUVL
| $37.2M | 0.1% |
+1,647,671
| New | +$47.8M |
|
|
OHPAU
88
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $36.3M | 0.1% |
3,671,788
+74,446
| +2% | +$741K |
|
89
Bilibili
BILI
$7.53B
| $36.3M | 0.1% |
547,961
+281,478
| +106% | +$24.1M |
|
|
DAWN
90
DELISTED
Day One Biopharmaceuticals
DAWN
| $28.7M | 0.08% |
1,211,396
-130,000
| -10% | -$3.12M |
|
91
GeneDx Holdings
WGS
$2.44B
| $22.8M | 0.06% |
+90,909
| New | +$31.2M |
|
|
GRCL
92
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
| $18.8M | 0.05% |
1,357,859
+27,531
| +2% | +$325K |
|
|
MEKA
93
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
| $11.1M | 0.03% |
+1,000,000
| New | +$11.1M |
|
94
On Holding
ONON
$10.3B
| $9.04M | 0.02% |
+300,000
| New | +$10.5M |
|
|
EM
95
DELISTED
Smart Share Global Ltd
EM
| $1.57M | ﹤0.01% |
470,000
| – | – |
|
|
96
Aon
AON
$75.6B
| – | – |
-2,903,054
| Closed | -$693M |
|
97
Bank of America
BAC
$448B
| – | – |
-7,174,216
| Closed | -$296M |
|
98
Kanzhun
BZ
$7.49B
| – | – |
-545,726
| Closed | -$21.6M |
|
99
Charter Communications
CHTR
$18.8B
| – | – |
-111,727
| Closed | -$80.6M |
|
100
Canadian National Railway
CNI
$76.4B
| – | – |
-537,655
| Closed | -$56.7M |
|
Similar funds
SAM
VIA
Viking Global Investors's Q3 2021 Portfolio in Review
As of Q3 2021, Viking Global Investors held 113 positions worth $36.5B, up 11% from $33B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Viking Global Investors deployed $5.21B of net new capital in Q3 2021, opening 25 new positions and adding to 26 existing holdings. Its largest new stake was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Amazon, an estimated $936M trimmed.
- Viking Global Investors's largest Q3 2021 buy was Ginkgo Bioworks: 8,476,379 shares worth $3.93B.
- Viking Global Investors added most to Humana in Q3 2021, an estimated $1.03B increase.
- Viking Global Investors's biggest Q3 2021 reduction was Amazon, cutting an estimated $936M.
- Viking Global Investors fully exited Aon in Q3 2021, selling an estimated $693M.
- Viking Global Investors's ten largest holdings make up 39% of its $36.5B portfolio in Q3 2021.
- Viking Global Investors opened 25 new positions and closed 17 in Q3 2021.
- Viking Global Investors's portfolio value rose 11% quarter-over-quarter to $36.5B.
Based on Viking Global Investors's 13F filing for Q3 2021, filed 15 Nov 2021.